BCR-ABL inhibitor


Entry
DG03161                     DGroup                                 
Name
BCR-ABL inhibitor
Type
Target
Member
DG00710  
Imatinib
 D08066  
Imatinib (INN)
 D01441  
Imatinib mesylate (USAN); Imatinib mesilate (JAN)  <JP/US>
DG00714  
Dasatinib
 D03658  
Dasatinib (JAN/INN)  <JP>
 D06414  
Dasatinib (USAN); Dasatinib hydrate (JAN)  <JP/US>
DG00716  
Nilotinib
 D08953  
Nilotinib (USAN/INN)
 D06413  
Nilotinib hydrochloride hydrate (JAN)  <JP/US>
DG00718  
Bosutinib
 D03252  
Bosutinib (USAN)
 D09728  
Bosutinib hydrate (JAN)  <JP/US>
DG00722  
Ponatinib
 D09950  
Ponatinib (USAN/INN)
 D09951  
Ponatinib hydrochloride (JAN/USAN)  <JP/US>
DG03004  
Asciminib
 D11403  
Asciminib (USAN/INN)
 D11404  
Asciminib hydrochloride (JAN/USAN)  <JP/US>
 » expand
Class
Antineoplastic
 DG01918  Tyrosine kinase inhibitor
Remark
ATC code: L01EA